Roland Turck, MD
Dr. Roland Turck is a biopharmaceutical industry expert and the Managing Partner of TurckBio. Roland has been involved in many significant projects, including improving the P&L of a division of a large Specialty Medicine company, developing regional strategies, preparing product launches, advising on clinical development strategies, as well as business development and partnering activities for small and large companies.
Roland was previously President of Bayer’s Global Specialty Medicine Business, which included the Oncology, Neurology, Orphan Drug, Ophthalmology and Diagnostic Imaging businesses. During his tenure, he orchestrated the launch of 4 major global brands, including Xofigo and Eylea, established Bayer as a player in Ophthalmology, re-organized the Diagnostic Imaging business, and aggressively expanded the Hemophilia and Neurology businesses.
Before joining Bayer, Roland was President of Bayer Schering Pharma’s Latin American business, with full P&L responsibility for all therapeutic areas and sales of US$1.5B. In earlier roles, he was CEO of subsidiaries in Canada and New Zealand and head of Marketing and R&D for a business unit in Germany.